Interactions between herbals medicines and drugs in chronic patients with complexity in Primary Care
e202108114
Keywords:
Herbals medicines, Phytotherapy, Herbs-drug interactions, Chronic patient with complexity, Primary Health care.Abstract
Background: Taking medicinal herbs (MH) is frequent in patients and can cause interactions with others medications. Consumption of MH could be high in chronic patients with complexity (CPC) and produce interactions with drugs and knowledge about these drugs in primary health care (PC) professionals about these interactions is low. The aim was to measure the prevalence of potencial interactions between HM and drugs in CPC and evaluate the degree of knowledge of PC professionals.
Methods: Descriptive observational study in a population of CPC assigned to two PC teams. We investigated MH consumption through interviews and review potential drug interactions. We evaluated the degree of professionals knowledge through a survey designed for the study. A descriptive analysis was carried out. The Student-t test for paired data was used to compare the means.The statistical significance was established at p <0.05.
Results: The survey was distributed among 179 patients, mean age 76.9 years old (DE 9.7), 54.6% women. 62.57% (112) take MH. We detected 88 potentially relevant interactions in 51 patients (45.54%). Of the 219 professionals interviewed 51.1% consider that their knowledge about MH were low and 64,4% thought that was important to know the mH consumption of their patients.
Conclusions: We detected a high prevalence of MH consumption in CPC and interactions between herbs medicinal and drugs. Lack of knowledge of PC health professionals is important. It’s necessary to record this consumption in the medical history and improve the knowledge of professionals about MH to detect possible interactions, reduce the associated risk and improve the quality of care.
Downloads
References
Bonet MA, Roldán M, Camprubi J. Estudi Etnobotànic de Gallecs (Vallés Oriental/Vallès Occidental). Bull. Inst. Hist. Nat. 2010-2011 76: 83-94.
Sprouse AA, van Breemen RB. Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements. Drug Metab Dispos. 2016 Feb;44 (2):162-171.
Tachjian A1, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010 Feb 9; 55(6):515-525. doi: 10.1016/j.jacc.2009.07.074
McLay JS1, Izzati N2, Pallivalapila AR3, Shetty A4, Pande B5, Rore C6, Al Hail M3, Stewart D. Pregnancy prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey. BMC Complement Altern Med. 2017, 543. https://doi.org/10.1186/s12906-017-2052-1
Neergheen-Bhujun VS. Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int. 2013;2013:804086. Doi: 10.1155/2013/804086
Scarton LA1, Del Fiol G, Treitler-Zeng Q. Completeness, accuracy, and presentation of information on interactions between prescription drugs and alternative medicines: an internet review. Stud Health Technol Inform. 2013;192:841-845.
Baulies MG, Torres RM, Martin A, Roig AM, Royo I, Orfila F. Hábitos de consumo de plantas medicinales en un centro de salud de Barcelona. Revista de fitoterapia. 2011. 11(1): 45-51.
Domènec M.C., Enseñat P., Félez C. Consumo de plantas medicinales en un barrio de Barcelona: la necesidad de registrar informáticamente este hábito. Revista de fitoterapia. 2016; 16(1): 57-64.
Alonso M.J., Capdevila C. Estudio descriptivo de la dispensación de fitoteràpia en la farmàcia catalana. Revista de Fitoterapia. 2005; 5 (1): 31-39.
Sanchez M, Gonzalez-Burogos E, Igesias I, Lozano R, Gomez-Serranillos MP. Current uses and knoledge of medicinal plants in the Autonomous Community of Madrid /Spain): a descriptive cross-sectional study. BMC Complementary Medicine and Therapeutics 2020; 20: 306-319
Vanaclocha B., Risco E., Cañigueral S. Interacciones entre preparados vegetales y farmacos de sintesis: Revision de las monografias de la EMA y ESCOP. Revista de fitoterapia. 2014; 14(1):5-36.
Morales-Olivas FJ, Estañ L. Interacciones Medica-mentosas . Nuevos aspectos (Revisión). Med Clín. 2006; 127(7):269-275.
Tomás-Guillen, Farriols-Danés, Cantarell-Aixendri, Juárez-Giménez. Interacciones entre plantas medicinales y fármacos immunosuporesores. Med Clin. 2006; 127 (5): 177-184.
Bartanero H et al. Analisis del consumo simultaneo de medicamentos y plantas medicinales en población española mayor de 65 años. Pharmaceutical Care 2017;19:69-79
Programa de Prevenció i Atenció a la Cronicitat (PPAC) (2012) Projecte de programa d’atenció al pacient crònic complex. Pla de Salut 2011-2015. Barcelona: PPAC. http://salutweb.gencat.cat/web/.content/home/ambits_tematics/linies_dactuacio/model_assistencial/atencio_al_malalt_cronic/documents/pcc__juny_2012.pdf
Agbabiaka TB, Wider B, Watson LK, Goodman C. Concurrent use of prescriptions drugs and herbal medicinal products in older adults: a systematic review. Drugs Aging. 2017; 34: 891-905.
Christensen CM, Morris RS, Chepkemoi Kapsandoy S, Archer M, Kuang J, Shane-McWhorter L, Bray BE and Zeng-Treitler Q. Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study. BMC Complementary and alternative Medicine. 2017;17: 272. DOI 10.1186/s12906-017-1630-6.
Al-Ramahi R, Jaradat N, Shalalfeh R, Nasir S, Manasra Y, Shalalfeh I, Esam Y. Evaluation of potential drug- herb interactions among a group of Palestinian patients with chronic diseases. BMC Complementary and alternative Medicine.2015;15: 221. DOI 10.1186/s12906-015-0764-7.
Djuv A, Nilsen OG and Steinsbekk A. The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study. BMC Complementary and Alternative Medicine. 2013, 13:295.doi: 10.1186/1472-6882-13-295
Posadzki P, Watson L, Ernst E. Herb–drug interactions: an overview of systematic reviews. BJCP. 2013 Mar;75(3):603-18. doi: 10.1111/j.1365-2125.2012.04350.x
Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E. Adverse events associated with interactions with
dietary and herbals suplements among inpatients. Br J Clin Pharmacol: 2017; 83: 836-845 DOI: 10.1111/bcp.13158
Real decreto legislativo 1/2015, de 24 de julio, por el que se aprueba el texto refundido de la Ley de garantías y uso racional de los medicamentos y productos sanitarios. Boletin Oficial del Estado 25 de julio 2015. Núm: 177. Sec I Pag 62935.
Kempre Jk, Gardiner P, Gobble J, Woods C. Expertise about herbs and dietary suplements among diverse Health professionals. BMC Complementary and alternative Medicine. 2006, 6:15. https://doi.org/10.1186/1472-6882-615
Cellini M, Attiope S, Seales P, Gray R, Ward A, Stephens M, Deuster PA. Dietary and suplements: Physician Knowledge ans adverse event reporting. Medicine & Science in Sports & Exercise. 2013; 45: 23-27.
Downloads
Published
How to Cite
License
Copyright (c) 2021 Elena Lázaro Romero, José Miranda Sánchez, Elena Zurilla Leonarte, Cristina Vedia Urgell, Mireia Massot Mesquida, Esther Serrano Serrano, Lídia Solanellas Colomer, Rosa Mª Martínez Luque, José Manuel Castillejo Medina, Elena Merino Domínguez, Gemma Seda Gombau, Pere Torán Monserrat
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
